Cargando…
Addition of a sequence from α(2)-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
BACKGROUND: The plasma protein α(2)-antiplasmin (α(2)AP) is cross-linked to fibrin in blood clots by the transglutaminase factor XIIIa, and in that location retards clot lysis. Competition for this effect could be clinically useful in patients with thrombosis. We hypothesized that fusion of N-termin...
Autores principales: | Sheffield, William P, Eltringham-Smith, Louise J, Gataiance, Sharon, Bhakta, Varsha |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654442/ https://www.ncbi.nlm.nih.gov/pubmed/19257897 http://dx.doi.org/10.1186/1472-6750-9-15 |
Ejemplares similares
-
Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa
por: Sheffield, William P, et al.
Publicado: (2011) -
A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
por: Boudjeltia, K Zouaoui, et al.
Publicado: (2002) -
Fibrin Clot Formation and Lysis in Plasma
por: Larsen, Julie Brogaard, et al.
Publicado: (2020) -
Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause
por: Hofer, Stefanie, et al.
Publicado: (2019) -
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss
por: Sheffield, William P., et al.
Publicado: (2018)